US FDA approved drugs from 2015–June 2020: a perspective
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …
The pharmaceutical industry in 2020. An analysis of FDA drug approvals from the perspective of molecules
BG de La Torre, F Albericio - Molecules, 2021 - mdpi.com
Although the pharmaceutical industry will remember 2020 as the year of COVID-19, it is
important to highlight that this year has been the second-best—together with 1996—in terms …
important to highlight that this year has been the second-best—together with 1996—in terms …
The pharmaceutical industry in 2019. An analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio - Molecules, 2020 - mdpi.com
During 2019, the US Food and Drug Administration (FDA) approved 48 new drugs (38 New
Chemical Entities and 10 Biologics). Although this figure is slightly lower than that registered …
Chemical Entities and 10 Biologics). Although this figure is slightly lower than that registered …
The pharmaceutical industry in 2021. An analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio - Molecules, 2022 - mdpi.com
Similar to last year, 2021 will be remembered for the COVID-19 pandemic. Although five
vaccines have been approved by the two most important drug regulatory agencies, namely …
vaccines have been approved by the two most important drug regulatory agencies, namely …
An analysis of FDA-approved drugs: natural products and their derivatives
E Patridge, P Gareiss, MS Kinch, D Hoyer - Drug discovery today, 2016 - Elsevier
Highlights•Natural products contribute more than one-third of all FDA-approved NMEs.•The
absolute number of natural product approvals peaked in the 1990s and has since …
absolute number of natural product approvals peaked in the 1990s and has since …
The pharmaceutical industry in 2022: an analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio - Molecules, 2023 - mdpi.com
While 2021 ended with the world engulfed in the COVID-19 Omicron wave, 2022 has ended
in almost all countries, except China, with COVID-19 being likened to the flu. In this context …
in almost all countries, except China, with COVID-19 being likened to the flu. In this context …
A decade of FDA-approved drugs (2010–2019): trends and future directions
A total of 378 novel drugs and 27 biosimilars approved by the US Food and Drug
Administration (FDA) between 2010 and 2019 were evaluated according to approval …
Administration (FDA) between 2010 and 2019 were evaluated according to approval …
Anticancer drugs approved by the US food and drug administration from 2009 to 2020 according to their mechanism of action
Importance Both novel and next-in-class cancer drugs have a role in oncology, but the
relative development of each is understudied. Objective To characterize the mechanisms of …
relative development of each is understudied. Objective To characterize the mechanisms of …
An overview of FDA-approved new molecular entities: 1827–2013
MS Kinch, A Haynesworth, SL Kinch, D Hoyer - Drug discovery today, 2014 - Elsevier
Highlights•1453 new molecular entities (NMEs) approved as therapeutics in the USA.•As a
consequence of consolidation, ten companies control more than two-thirds of all …
consequence of consolidation, ten companies control more than two-thirds of all …
New drug approvals for 2021: Synthesis and clinical applications
S Yuan, DS Wang, H Liu, SN Zhang, WG Yang… - European Journal of …, 2023 - Elsevier
Abstract 50 New drugs including 36 chemical entities and 14 biologics were approved by
the US Food and Drug Administration during 2021. Among the marketed drugs, 31 new …
the US Food and Drug Administration during 2021. Among the marketed drugs, 31 new …